Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-008484
Filing Date
2001-03-27
Accepted
2001-03-27 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2042491z10-k.txt 10-K 272843
2 EXHIBIT 10.11 a2042491zex-10_11.txt EX-10.11 97740
3 EXHIBIT 10,12 a2042491zex-10_12.txt EX-10.12 51256
4 EXHIBIT 10.13 a2042491zex-10_13.txt EX-10.13 37985
5 EXHIBIT 10.14 a2042491zex-10_14.txt EX-10.14 2812
6 EXHIBIT 10.15 a2042491zex-10_15.txt EX-10.15 37566
7 EXHIBIT 21 a2042491zex-21.txt EX-21 354
8 EXHIBIT 23 a2042491zex-23.txt EX-23 803
  Complete submission text file 0000912057-01-008484.txt   503730
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 1580350
SIC: 2835 In Vitro & In Vivo Diagnostic Substances